67 related articles for article (PubMed ID: 16317430)
1. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
Goekkurt E; Hoehn S; Wolschke C; Wittmer C; Stueber C; Hossfeld DK; Stoehlmacher J
Br J Cancer; 2006 Jan; 94(2):281-6. PubMed ID: 16317430
[TBL] [Abstract][Full Text] [Related]
2. The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer.
Sun J; Wang X; Zhang Z; Zeng Z; Ouyang S; Kang W
Front Oncol; 2021; 11():641304. PubMed ID: 33937042
[TBL] [Abstract][Full Text] [Related]
3. Influence of glutathione S transferase A1 gene polymorphism (-69C > T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis.
Attia DHS; Eissa M; Samy LA; Khattab RA
Clin Rheumatol; 2021 Feb; 40(2):753-762. PubMed ID: 32661806
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferases genes variants and chemotherapy efficacy in gastrointestinal cancer patients: a meta-analysis based on 50 pharmacogenetic studies.
Sun Y; Pan J; Tong X; Chen E; Yan W; Wu M; Qu Q; Qu J
J Cancer; 2019; 10(13):2915-2926. PubMed ID: 31281468
[No Abstract] [Full Text] [Related]
5. Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma.
Ogino S; Konishi H; Ichikawa D; Matsubara D; Shoda K; Arita T; Kosuga T; Komatsu S; Shiozaki A; Okamoto K; Kishimoto M; Otsuji E
Cancer Sci; 2019 Feb; 110(2):795-804. PubMed ID: 30499150
[TBL] [Abstract][Full Text] [Related]
6. Relevance of
Zhong L; Fu Q; Zhou S; Chen L; Peng Q
BMJ Open; 2018 May; 8(5):e020767. PubMed ID: 29804062
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism of
Li Q; Qu F; Li R; He X; Zhai Y; Chen W; Zheng Y
Oncotarget; 2017 Dec; 8(67):110861-110876. PubMed ID: 29340022
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
Smyth E; Zhang S; Cunningham D; Wotherspoon A; Soong R; Peckitt C; Valeri N; Fassan M; Rugge M; Okines A; Allum W; Stenning S; Nankivell M; Langley R; Tan P
Clin Cancer Res; 2017 Dec; 23(24):7543-7549. PubMed ID: 28972045
[No Abstract] [Full Text] [Related]
9. Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.
Gusella M; Pezzolo E; Modena Y; Barile C; Menon D; Crepaldi G; La Russa F; Fraccon AP; Pasini F
Pharmacogenomics J; 2018 Jan; 18(1):14-22. PubMed ID: 28607505
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies.
Meulendijks D; Rozeman EA; Cats A; Sikorska K; Joerger M; Deenen MJ; Beijnen JH; Schellens JHM
Pharmacogenomics J; 2017 Oct; 17(5):441-451. PubMed ID: 27995989
[TBL] [Abstract][Full Text] [Related]
11. ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.
Li Z; Xing X; Shan F; Li S; Li Z; Xiao A; Xing Z; Xue K; Li Z; Hu Y; Jia Y; Miao R; Zhang L; Bu Z; Wu A; Ji J
Oncotarget; 2016 Aug; 7(34):55449-55457. PubMed ID: 27487151
[TBL] [Abstract][Full Text] [Related]
12. Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports.
Liu H; Shi W; Zhao L; Dai D; Gao J; Kong X
Onco Targets Ther; 2016; 9():3683-94. PubMed ID: 27382306
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
Abbas M; Kushwaha VS; Srivastava K; Banerjee M
PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
[TBL] [Abstract][Full Text] [Related]
14. GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.
Deng X; Yang X; Cheng Y; Liu X; Li X; Zhao R; Qin C; Lu Q; Yin C
Sci Rep; 2015 Sep; 5():14000. PubMed ID: 26354850
[TBL] [Abstract][Full Text] [Related]
15. SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy.
Xu Z; Chen Y; Gu D; Lee NP; Sun S; Gong W; Tan Y; Luk JM; Chen J
Am J Transl Res; 2015; 7(2):401-10. PubMed ID: 25901207
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.
Zhao T; Gu D; Xu Z; Huo X; Shen L; Wang C; Tang Y; Wu P; He J; Gong W; He ML; Chen J
Oncotarget; 2015 Apr; 6(11):9564-76. PubMed ID: 25840420
[TBL] [Abstract][Full Text] [Related]
17. Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
Roco A; Cayún J; Contreras S; Stojanova J; Quiñones L
Front Genet; 2014; 5():391. PubMed ID: 25452763
[TBL] [Abstract][Full Text] [Related]
18. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy.
Liu S; Yi Z; Ling M; Shi J; Qiu Y; Yang S
Tumour Biol; 2014 Oct; 35(10):9897-904. PubMed ID: 24996541
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
